Search

Author/Creator Bertetti, Anselmo

1. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Issue 12 (December 2021)

Authors:
Marconi, Vincent C; Ramanan, Athimalaipet V; de Bono, Stephanie; Kartman, Cynthia E; Krishnan, Venkatesh; Liao, Ran; Piruzeli, Maria Lucia B; Goldman, Jason D; Alatorre-Alexander, Jorge; de Cassia Pellegrini, Rita; Estrada, Vicente; Som, Mousumi; Cardoso, Anabela; Chakladar, Sujatro; Crowe, Brend...
Journal:
Lancet
Issue:
Volume 9:Issue 12(2021)
Page Start:
1407
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial. (April 2021)

Authors:
Lopardo, Gustavo; Belloso, Waldo H.; Nannini, Esteban; Colonna, Mariana; Sanguineti, Santiago; Zylberman, Vanesa; Muñoz, Luciana; Dobarro, Martín; Lebersztein, Gabriel; Farina, Javier; Vidiella, Gabriela; Bertetti, Anselmo; Crudo, Favio; Alzogaray, Maria Fernanda; Barcelona, Laura; Teijeiro, Rica...
Journal:
EClinicalMedicine
Issue:
Volume 34(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search